Keywords: Small Animals, Tumors, Fluorine MRI
Motivation: Imaging is often combined with biopsies to diagnose and monitor cancer progression, but biopsies can be invasive and time-consuming.
Goal(s): A promising alternative is 19F nanoemulsion as a contrast agent for MRI, which labels systemic macrophages, enabling noninvasive tracking of macrophages and tumor growth after treatment.
Approach: This study used a fluorine nanoemulsion and 19F MRI to observe macrophage dynamics in murine cancer models post-radiation therapy or immunotherapy.
Results: Our radiation therapy study showed significantly higher fluorine signals and reduced tumor growth in treated mice. Our immunotherapy study achieved a 75% response rate, distinguishing responders from non-responders through tumor size obtained via MRI.
Impact: 19F MRI enables noninvasive monitoring of macrophage dynamics during radiation therapy and immunotherapy treatments, as well as anticipate tumor growth. This approach will be invaluable for future research on the role of inflammation in tumor response to therapy and recurrence.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords